Forskning
Udskriv Udskriv
Switch language
Bispebjerg Hospital - en del af Københavns Universitetshospital
Udgivet

Introduction and transmission of SARS-CoV-2 lineage B.1.1.7, Alpha variant, in Denmark

Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

DOI

  1. Breast cancer risks associated with missense variants in breast cancer susceptibility genes

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Trans-ethnic gut microbial signatures of prediabetic subjects from India and Denmark

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  3. Trans-ethnic gut microbiota signatures of type 2 diabetes in Denmark and India

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  4. Whole blood co-expression modules associate with metabolic traits and type 2 diabetes: an IMI-DIRECT study

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  5. Relation between NOD2 genotype and changes in innate signaling in Crohn's disease on mRNA and miRNA levels

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  1. Validation of registration of pharmacological treatment in the Danish Hip and Knee Arthroplasty Registers

    Publikation: Bidrag til tidsskriftTidsskriftartikelpeer review

  2. Shift From Adalimumab Originator to Biosimilars in Denmark

    Publikation: Bidrag til tidsskriftLetterpeer review

  • Danish COVID-19 Genome Consortium (DCGC)
Vis graf over relationer

BACKGROUND: In early 2021, the SARS-CoV-2 lineage B.1.1.7 (Alpha variant) became dominant across large parts of the world. In Denmark, comprehensive and real-time test, contact-tracing, and sequencing efforts were applied to sustain epidemic control. Here, we use these data to investigate the transmissibility, introduction, and onward transmission of B.1.1.7 in Denmark.

METHODS: We analyzed a comprehensive set of 60,178 SARS-CoV-2 genomes generated from high-throughput sequencing by the Danish COVID-19 Genome Consortium, representing 34% of all positive cases in the period 14 November 2020 to 7 February 2021. We calculated the transmissibility of B.1.1.7 relative to other lineages using Poisson regression. Including all 1976 high-quality B.1.1.7 genomes collected in the study period, we constructed a time-scaled phylogeny, which was coupled with detailed travel history and register data to outline the introduction and onward transmission of B.1.1.7 in Denmark.

RESULTS: In a period with unchanged restrictions, we estimated an increased B.1.1.7 transmissibility of 58% (95% CI: [56%, 60%]) relative to other lineages. Epidemiological and phylogenetic analyses revealed that 37% of B.1.1.7 cases were related to the initial introduction in November 2020. The relative number of cases directly linked to introductions varied between 10 and 50% throughout the study period.

CONCLUSIONS: Our findings corroborate early estimates of increased transmissibility of B.1.1.7. Both substantial early expansion when B.1.1.7 was still unmonitored and continuous foreign introductions contributed considerably to case numbers. Finally, our study highlights the benefit of balanced travel restrictions and self-isolation procedures coupled with comprehensive surveillance efforts, to sustain epidemic control in the face of emerging variants.

OriginalsprogEngelsk
Artikelnummer47
TidsskriftGenome Medicine
Vol/bind14
Udgave nummer1
Sider (fra-til)47
ISSN1756-994X
DOI
StatusUdgivet - 4 maj 2022

Bibliografisk note

© 2022. The Author(s).

ID: 77898282